Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

HRTX Heron Therapeautics Inc

3,33

0,28 (9,18%)

Nach Börsenschluss

Zuletzt aktualisiert: 00:47:35

Verzögert um 15 Minuten

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

null

Heron Therapeautics (NASDAQ:HRTX)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Heron Therapeautics Charts.

Heron Therapeautics (NASDAQ:HRTX)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Heron Therapeautics Charts.

News Heron Therapeautics Inc

Form 8-K - Current report
Dienstag 18 Juni 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 17 Juni 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 7 Juni 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Freitag 31 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 29 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN")
Mittwoch 29 Mai 2024 (4 Wochen vor) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 7 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 7 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)

Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates
Dienstag 7 Mai 2024 (2 Monate vor) • PR Newswire (US)

Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
Mittwoch 24 April 2024 (2 Monate vor) • PR Newswire (US)

Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City
Donnerstag 11 April 2024 (3 Monate vor) • PR Newswire (US)

Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
Donnerstag 28 März 2024 (3 Monate vor) • PR Newswire (US)

Weitere Heron Therapeautics Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen